This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Divine Skin Q4 Tops $3 Million; 2011 Revenue Reaches $9.6 Million, Up 78% Over 2010

MIAMI BEACH, Fla., Feb. 9, 2012 /PRNewswire/ -- Today Divine Skin (OTC Bulletin Board: DSKX) released preliminary revenue figures for the fourth quarter, $3.1 million, up 63 percent over the same quarter of 2010 and up 48 percent over the third quarter of 2011. For the year 2011, revenue totaled $9.6 million, up 78 percent over 2010.

Divine Skin CEO Daniel Khesin said, "While we experienced nearly triple-digit growth in 2011, we are far from satisfied with this result. We believe this number will improve significantly as we continue to optimize logistics.

"Our formulas are very complex, and bringing these one-of-a-kind products to market is a challenge," he continued. "The issue is our top priority going forward, and we are very excited about our prospects for 2012."

Divine Skin had a busy year. Notable achievements include:
  • SALONS. In 2011 Divine Skin established new agreements with 19 salon distributors around the United States to sell its flagship brand, DS Laboratories. The new partners, each a leader in its market, employ a network of nearly 1,000 sales consultants who reach a combined 150,000 salons. In 2011 they penetrated 10 percent of their outlets, and in 2012 they project to have 30 percent selling the brand. Salon distribution, which represented a small fraction of sales prior to 2011, has become Divine Skin's fastest-growing segment, responsible for nearly half of its domestic business.
  • FANTASTIC SAMS. DS Laboratories installed more locations of the huge Fantastic Sams chain of salons, supplying unique product, professional training, and promotional assistance.
  • NEIMAN MARCUS. Prestigious fashion retailer Neiman Marcus picked up Divine Skin's super-premium Sigma Skin line for hair and skin.
  • WHOLE FOODS. The NutraOrigin line was tested successfully in Whole Foods, a chain of 297 retail stores in the United States plus seven in Canada and six in the United Kingdom.
  • NANOXIDIL. The company introduced a new compound, Nanoxidil, engineered to surpass minoxidil for efficacy and tolerability. It debuted in the new topical treatment Spectral.DNC-N.
  • ASTRESSIN-B. DS Laboratories became the first biotech brand to commercialize a hair-growth treatment based on astressin-B, a peptide (protein fragment) newly discovered to regrow hair on bald mice. It debuted in the new Spectral.F7.
  • API SOLUTION 9. The Polaris Research brand rolled out API Solution 9, a customizable topical kit to be sold by physicians. It delivers unprecedented concentrations of minoxidil, finasteride, and alfatradiol, and it has no direct competitor.
  • ORAL ANALGESIC. Divine Skin announced its foray into pharmaceuticals with an oral analgesic to compete with Tylenol, Advil, and aspirin. Like the company's other products, it targets the market that appreciates more advanced biotechnology.
  • NUTRAORIGIN. Expanding into nutritional supplements, Divine Skin acquired rights to NutraOrigin, with 63 formulas that can be incorporated easily into any health regimen.
  • BRAZIL. A new Brazilian distributor conducted the successful trials and earned the required certificates needed to import product into that burgeoning market of 201 million eager consumers.
  • RANBAXY LABORATORIES. Divine Skin announced a global partnership with India's largest pharmaceutical company, Ranbaxy Laboratories, to sell DS Laboratories products worldwide.
  • CAPITALIZATION. Divine Skin secured new capital through Littlebanc Advisors to be used to build mounting inventory and service expanding distribution.
  • AUDITORS. Top-30 auditing firm Cherry, Bekaert & Holland LLP began advising the company, bringing valuable experience with publicly traded manufacturers and lending greater credibility to financial statements.

About Divine Skin

Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs